Tsukuba, Japan

Kimiyo Tabata

USPTO Granted Patents = 6 



Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Tsukuba, JP (2010 - 2012)
  • Tokyo, JP (2023 - 2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: **Innovator Kimiyo Tabata: Pioneering Cancer Treatment**

Introduction

Kimiyo Tabata, an accomplished inventor based in Tsukuba, Japan, has made significant contributions to the field of oncology through her innovative research and patented inventions. With a total of six patents, her work focuses on combining therapies that target cancer treatment, specifically utilizing antagonists and tyrosine kinase inhibitors.

Latest Patents

One of Kimiyo's latest patents discusses a combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer. The patent outlines combination therapies that incorporate an antagonist of the Programmed Death 1 receptor (PD-1) along with a multi-RTK inhibitor. The detailed disclosure includes the representation of the multi-RTK inhibitor by a specific formula involving alkyl, cycloalkyl, and various substituents. Additionally, this invention reveals a tumor therapeutic agent that combines a compound represented by the formula and an anti-PD-1 antibody, aiming to enhance the efficacy of cancer treatments.

Career Highlights

Throughout her career, Kimiyo has been affiliated with reputable organizations such as Eisai R&D Management Co., Ltd. and Eisai Company, Limited. Her roles in these companies have contributed to the advancement of cancer therapies, showcasing her expertise and dedication to improving patient outcomes through innovative solutions.

Collaborations

Kimiyo has worked alongside distinguished colleagues like Richard S. Clark and Tadashi Nagakura, enhancing her research through collaboration and interdisciplinary approaches. This teamwork has allowed for the exchange of ideas and knowledge, further pushing the boundaries of cancer treatment innovations.

Conclusion

Kimiyo Tabata exemplifies the essence of innovation in the medical field, especially in cancer treatment. With her impressive portfolio of patents and collaborative work in renowned companies, she continues to pave the way for advancements that hold promise for better therapeutic outcomes. As her research progresses, the impact of her inventions will likely be felt in both clinical practices and patient lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…